ABCC1 and pancreatic neoplasm: The eight CpGs targeted by our ABCC1 method are directly upstream of the CpGs that have been found to be hypomethylated in the pancreatic cancer cell line SW1990 and its drug-resistant subline SW1990/GZ [30].